CIK 0001645113
- Large accelerated filer
NovoCure Ltd
Sign in to watch- Ticker
- NVCR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +44 1534756700
- Business address
- NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
- 4 Open-market sale Director sold 407 shares at $69.61 ($28,331)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 2,427 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 2,427 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Medical Officer sold 4,205 shares at an average $63.17 ($265,646)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Chief Financial Officer acquired 5,040 shares (option exercise)
- 4 Open-market sale Chief Commercial Officer sold 3,669 shares at $71.19 ($261,196)
- 4 Open-market sale Chief Commercial Officer sold 7,775 shares at an average $69.73 ($542,116)
- 4 Open-market sale Chief Development Officer sold 744 shares at $70.10 ($52,154)
- 4 Open-market sale Chief Human Resources Officer sold 1,037 shares at $70.10 ($72,694)
- 4 Open-market sale Chief Operating Officer sold 2,923 shares at $70.10 ($204,902)
- 4 Open-market sale Chief Financial Officer sold 759 shares at $70.10 ($53,206)
- 4 Open-market sale General Counsel sold 2,339 shares at $70.10 ($163,964)
- 4 Open-market sale Executive Chairman sold 2,385 shares at $70.10 ($167,189)
- 4 Open-market sale General Counsel sold 3,067 shares at an average $71.87 ($220,414)
Page 12 of 39 · 780 filings